Micro
Aftermath
Active
Mizuho raises price target on Lam Research
Activity declining — narrative losing relevance.
Score
0.2
Velocity
▲ 0.0
Articles
5
Sources
1
Sentiment Timeline
Event Timeline
🤖
AI Overview
Mizuho raises price targets on tech and healthcare stocks, reflecting optimism in AI and managed care sectors.
On June 8, 2026, Mizuho Securities raised its price target on Lam Research (LRCX) to $380, up from $330, maintaining an 'Outperform' rating. The firm also boosted its target on UnitedHealth Group (UNH) to $460 from $440, reiterating an 'Outperform' rating. Earlier, Mizuho had praised Arm Holdings (ARM) as one of the 'Best Up and Coming AI Stocks to Buy Now', following its 2023 IPO.
These upgrades reflect bullish sentiment in the AI and managed care sectors. Lam Research, a key player in wafer fab equipment, benefits from increased semiconductor demand driven by AI and 5G. UnitedHealth's outlook improves due to managed care's resilience and growth potential. The upgrades may prompt investors to re-evaluate these stocks, potentially driving up their valuations.
What to watch next: Lam Research's Q3 earnings on July 27, 2026, and UnitedHealth's Q2 results on July 19, 2026, will provide updates on their respective business performances. Additionally, monitor AI and semiconductor industry trends, as they could further impact Lam Research's outlook.
On June 8, 2026, Mizuho Securities raised its price target on Lam Research (LRCX) to $380, up from $330, maintaining an 'Outperform' rating. The firm also boosted its target on UnitedHealth Group (UNH) to $460 from $440, reiterating an 'Outperform' rating. Earlier, Mizuho had praised Arm Holdings (ARM) as one of the 'Best Up and Coming AI Stocks to Buy Now', following its 2023 IPO.
These upgrades reflect bullish sentiment in the AI and managed care sectors. Lam Research, a key player in wafer fab equipment, benefits from increased semiconductor demand driven by AI and 5G. UnitedHealth's outlook improves due to managed care's resilience and growth potential. The upgrades may prompt investors to re-evaluate these stocks, potentially driving up their valuations.
What to watch next: Lam Research's Q3 earnings on July 27, 2026, and UnitedHealth's Q2 results on July 19, 2026, will provide updates on their respective business performances. Additionally, monitor AI and semiconductor industry trends, as they could further impact Lam Research's outlook.
AI Overview as of Jun 12, 2026
Timeline
Last UpdatedJun 04, 2026